EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Oregon Public Employees Retirement Fund Has $46.75 Million Position in AbbVie Inc. $ABBV - Markets Daily
AbbVie Inc. $ABBV Holdings Decreased by State of Alaska Department of Revenue
Nisa Investment Advisors LLC Boosts Holdings in AbbVie Inc. $ABBV - Markets Daily
Revolution Medicines (NASDAQ:RVMD) Reaches New 12-Month High - Still a Buy? - Markets Daily
AbbVie Inc. $ABBV Shares Bought by Duncker Streett & Co. Inc.
AbbVie Inc. $ABBV Stake Raised by Oregon Public Employees Retirement Fund - Stock Observer
AbbVie Inc. $ABBV Shares Acquired by Capital Investment Advisors LLC
Is AbbVie (ABBV) Still Attractive After Strong 1-Year And 5-Year Share Price Gains?
AbbVie (NYSE:ABBV) Updates FY 2025 Earnings Guidance - Stock Observer
Health Care Down Amid Deal Skepticism - Health Care Roundup | Morningstar
AbbVie (NYSE:ABBV) Trading Down 3.9% - Here's Why
Traders Purchase High Volume of Call Options on Revolution Medicines (NASDAQ:RVMD) - Markets Daily
AbbVie Flags $1.3B Charge, Cuts Fourth-Quarter EPS Outlook
Legacy CG LLC Buys 14,257 Shares of AbbVie Inc. $ABBV
AbbVie (ABBV) Stock Falls After Company Denies Revolution Medicines Buyout Talks
Investors Purchase Large Volume of Call Options on Revolution Medicines (NASDAQ:RVMD) - Stock Observer
AbbVie Inc. $ABBV Stock Position Increased by HB Wealth Management LLC
AbbVie (NYSE:ABBV) Issues FY 2025 Earnings Guidance
AbbVie (NYSE:ABBV) Releases Q4 2025 Earnings Guidance
AbbVie's (NYSE:ABBV) Dividend Will Be Increased To $1.73
AbbVie Inc. $ABBV Stock Holdings Increased by CX Institutional
Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?
AbbVie (NYSE:ABBV) Shares Up 4.3% - What's Next?
AbbVie Says It's Not in Talks to Buy Revolution Medicines (1)
AbbVie denies media reports of talks to buy Revolution Medicines
Dow Jones Top Company Headlines at 3 PM ET: AbbVie Near Deal for Revolution Medicines | Anthropic ... | Morningstar
AbbVie (NYSE:ABBV) Is Increasing Its Dividend To $1.73
Securian Asset Management Inc. Sells 7,037 Shares of AbbVie Inc. $ABBV - Markets Daily
KLP Kapitalforvaltning AS Has $172.38 Million Stake in AbbVie Inc. $ABBV - Markets Daily
AbbVie Inc. $ABBV Stake Boosted by Park Avenue Securities LLC
AbbVie Inc. $ABBV Shares Purchased by KLP Kapitalforvaltning AS
Sivik Global Healthcare LLC Takes Position in AbbVie Inc. $ABBV
AbbVie to Host Full-Year and Fourth-Quarter 2025 Earnings Conference Call
Assessing AbbVie (ABBV) Valuation After Recent Share Price Gain And Mixed Return Profile
AbbVie Inc. $ABBV Shares Acquired by Cerity Partners LLC
AbbVie Inc. $ABBV Stock Holdings Increased by Capital & Planning LLC
AbbVie Inc Stock Live Price, Chart, Analysis, News & Forecast - Buy, Sell & Trade US Equities Today
Alnuctamab, a bivalent B-cell maturation antigen-targeting T cell engager for patients with relapsed or refractory multiple myeloma: results from a phase 1, first-in-human study
Molecular and functional characterization of the B-cell receptor in chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis
AbbVie (NYSE:ABBV) Stock Price Up 1.7% - Still a Buy?
AbbVie Inc. $ABBV Shares Bought by Spirepoint Private Client LLC
Greenleaf Trust Sells 28,666 Shares of AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Holdings Lifted by Torray Investment Partners LLC
MAVIRET® receives Health Canada Approval for the Treatment of Acute Hepatitis C Virus
AbbVie Inc. $ABBV Shares Purchased by Sitrin Capital Management LLC
Will AbbVie's (ABBV) Zelgen Lung Cancer Deal Reshape Its Post‑Humira Resilience Narrative?
Torray Investment Partners LLC Has $23.53 Million Stake in AbbVie Inc. $ABBV - Stock Observer
Geneos Wealth Management Inc. Cuts Holdings in AbbVie Inc. $ABBV - Stock Observer
AbbVie (NYSE:ABBV) Stock Price Down 3.8% - Time to Sell?
Promising Pharmaceutical Stocks To Follow Now - January 5th - Markets Daily
Assessing AbbVie (ABBV) Valuation After Strong Multi‑Year Shareholder Returns
Railway Pension Investments Ltd Raises Holdings in AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Holdings Raised by CWA Asset Management Group LLC
Commonwealth Equity Services LLC Cuts Holdings in AbbVie Inc. $ABBV
Asset Management One Co. Ltd. Raises Holdings in AbbVie Inc. $ABBV
Is AbbVie (ABBV) Still Attractively Priced After A 31.8% One Year Gain?
AbbVie Inc. $ABBV Holdings Lifted by Capital Advisors Inc. OK
Davis Capital Management Purchases New Stake in AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Shares Acquired by Gateway Investment Advisers LLC - Stock Observer
AbbVie (NYSE:ABBV) Downgraded by Wall Street Zen to Buy - Daily Political
Analysts' Downgrades for January 3rd (ABBV, ACAD, ACLS, AFRM, ARI, ARLP, AROW, ASAN, ASB, AUGO) - Markets Daily
Pharmaceutical Stocks To Keep An Eye On - January 3rd - Stock Observer
PICTET BANK & TRUST Ltd Invests $1.61 Million in AbbVie Inc. $ABBV
First Pacific Financial Increases Stock Holdings in AbbVie Inc. $ABBV
SteelPeak Wealth LLC Has $5.98 Million Position in AbbVie Inc. $ABBV
Bell Bank Sells 10,943 Shares of AbbVie Inc. $ABBV
Altfest L J & Co. Inc. Has $5.90 Million Stake in AbbVie Inc. $ABBV
First Pacific Financial Boosts Stock Holdings in AbbVie Inc. $ABBV - Stock Observer
AbbVie (NYSE:ABBV) Downgraded to "Buy" Rating by Wall Street Zen
Ironwood Reaffirms FY2025 Revenue Outlook, Sees Growth In FY2026; Stock Surges
Spotlight on Health ETFs as NVO & LLY Cut Obesity Drug Price in China
Hofer & Associates. Inc Purchases New Position in AbbVie Inc. $ABBV - Markets Daily
- Expects full-year 2026 LINZESS® U.S. net sales of $1.125 t
AbbVie Inc. (NYSE:ABBV) Receives Average Recommendation of "Moderate Buy" from Analysts - Markets Daily
New year sees Abbvie, Zelgen in $1.1B T-cell engager deal | BioWorld
Miracle Mile Advisors LLC Grows Position in AbbVie Inc. $ABBV - Markets Daily
Nicholas Wealth LLC. Cuts Stock Holdings in AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Shares Bought by Los Angeles Capital Management LLC
Miracle Mile Advisors LLC Has $13.65 Million Stock Position in AbbVie Inc. $ABBV - Stock Observer
Nicholas Wealth LLC. Decreases Holdings in AbbVie Inc. $ABBV - Daily Political
Shum Financial Group Inc. Purchases Shares of 5,336 AbbVie Inc. $ABBV - Daily Political
AbbVie (ABBV) Maintains Immunology Dominance as Analysts Downplay Competitive Threat From J&J's Tremfya to Skyrizi Market Share
VIRGINIA RETIREMENT SYSTEMS ET Al Grows Stake in AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Shares Acquired by Smith Salley Wealth Management
AbbVie Inc. $ABBV Shares Purchased by Brendel Financial Advisors LLC
Diversified Trust Co Purchases 10,891 Shares of AbbVie Inc. $ABBV
Ascent Group LLC Has $7.47 Million Holdings in AbbVie Inc. $ABBV
BofA Cuts AbbVie (ABBV) Target While Maintaining Neutral View
Sowell Financial Services LLC Sells 8,716 Shares of AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Shares Sold by Sapient Capital LLC
AbbVie (NYSE:ABBV) - Stock Analysis - Simply Wall St
AbbVie Inc. (NYSE:ABBV) Given Average Recommendation of "Moderate Buy" by Brokerages
Meyer Handelman Co. Has $39.35 Million Stake in AbbVie Inc. $ABBV - Stock Observer
AbbVie Inc. $ABBV Shares Sold by Highland Capital Management LLC
5,829 Shares in AbbVie Inc. $ABBV Bought by Regent Peak Wealth Advisors LLC
Feasibility of outpatient administration of ciltacabtagene autoleucel and reduction in healthcare utilization cost: the Vanderbilt experience
World Investment Advisors Increases Position in AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Shares Sold by Pacer Advisors Inc.
